The Pfizer Independent Medical Education Grant for New Mechanisms and Emerging Treatment Options in Metastatic Castration-Resistant Prostate Cancer (mCRPC) supports independent medical education initiatives designed to improve healthcare professionals’ understanding of emerging therapeutic mechanisms and treatment options in mCRPC.
The program places particular emphasis on EZH2 inhibition, novel mechanisms of disease, the potential role of combined EZH2 and androgen receptor (AR) inhibition in overcoming AR pathway inhibitor resistance, therapies beyond chemotherapy, and ongoing clinical trials that may provide treatment options for patients. The program prioritizes the United States and Europe while encouraging proposals with global reach.
Eligibility Criteria
- Applicant organizations must be based in the United States or Europe.
- Eligible organizations may include medical, dental, nursing, allied health, and pharmacy schools.
- Healthcare institutions, both large and small, may apply.
- Professional organizations and medical societies are eligible.
- Only organizations are eligible to receive funding; individuals and independent medical practice groups are not eligible.
- The requesting organization must be legally able to receive funding directly from Pfizer Inc.
Funding Details
- Funding range: $75,000–$250,000 per project
- Maximum request: $250,000
- Estimated total program budget: $750,000
- Project duration: 18–24 months
Deadline
- Application Deadline: October 21, 2026, at 11:59 PM Eastern Time
- RFP release date: September 9, 2026
- Grant award notification: November 19, 2026
- Anticipated project start date: January 1, 2027
- Anticipated project end date: December 31, 2028
Further Information
- Applications must be submitted through Pfizer’s grant management system and include the required project proposal/protocol.
- Applicants should submit a Project Plan/Proposal or Meeting Agenda and the required supporting documentation through the online application system.
- For the official Pfizer grant application and program information: Pfizer Grant Requester Portal